Childhood cancer and the Jehovah's Witness faith. (abre uma nova janela)

Frankel LS, Damme CJ, Eys JV.

Fonte‎: Pediatrics 1977;60(6):916-21.

Indexado‎: PubMed 600607

https://www.ncbi.nlm.nih.gov/pubmed/600607 (abre uma nova janela)

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children's Oncology Group trial AAML0531. (abre uma nova janela)

Gamis AS, Alonzo TA, Meshinchi S, Sung L, Gerbing RB, Raimondi SC, Hirsch BA, Kahwash SB, Heerema-McKenney A, Winter L, Glick K, Davies SM, Byron P, Smith FO, Aplenc R

Fonte‎: J Clin Oncol 2014;32(27):3021-32.

Indexado‎: PubMed 25092781

DOI‎: 10.1200/JCO.2014.55.3628

https://www.ncbi.nlm.nih.gov/pubmed/25092781 (abre uma nova janela)

Red blood cell transfusion and outcome in cancer. (abre uma nova janela)

Iqbal N, Haider K, Sundaram V, Radosevic J, Burnouf T, Seghatchian J, Goubran H

Fonte‎: Transfus Apher Sci 2017;56(3):287-90.

Indexado‎: PubMed 28602484

DOI‎: 10.1016/j.transci.2017.05.014

https://www.ncbi.nlm.nih.gov/pubmed/28602484 (abre uma nova janela)

Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases. (abre uma nova janela)

Oh SY, Kim SH, Kwon HC, Lee S, Kim KH, Kwon KA, Lee JH, Lee KY, Kim HJ

Fonte‎: Support Care Cancer 2010;18(10):1341-6.

Indexado‎: PubMed 19841950

DOI‎: 10.1007/s00520-009-0759-3

https://www.ncbi.nlm.nih.gov/pubmed/19841950 (abre uma nova janela)